Name: UMIN ID:
Unique ID issued by UMIN | UMIN000031686 |
---|---|
Receipt number | R000036188 |
Scientific Title | The effects of peroral administration of Tofogliflozin(SGLT2 inhibitor) on endogenous glucose production and insulin clearance, single effet and chronic effect. |
Date of disclosure of the study information | 2018/03/16 |
Last modified on | 2019/06/13 21:45:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/03/12 17:46:57 | ||
2 | Update | 2018/03/14 16:39:06 | Public title Acronym |
|
3 | Update | 2018/03/14 16:42:15 | Public title Public title |
|
4 | Update | 2018/03/14 16:46:12 | Genomic information Narrative objectives1 |
|
5 | Update | 2018/03/14 16:54:25 | Narrative objectives1 |
|
6 | Update | 2018/03/14 16:57:44 | Public title Public title |
|
7 | Update | 2018/03/14 17:05:47 | Narrative objectives1 Primary outcomes Key secondary outcomes |
|
8 | Update | 2018/03/14 17:37:47 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
9 | Update | 2018/03/14 17:40:00 | Email1 |
|
10 | Update | 2018/03/16 10:22:33 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
11 | Update | 2018/03/16 11:18:18 | Interventions/Control_1 Interventions/Control_1 |
|
12 | Update | 2018/12/10 09:49:48 | Recruitment status |
|
13 | Update | 2019/06/13 21:45:36 | Recruitment status Date of IRB Last follow-up date Other related information |